NSIM
HZNP

North Star Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

North Star Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150
Closed -$17.4K – 1300
2023
Q3 		$17.4K Hold
150
– – ﹤0.01% 743
2023
Q2 		$15.4K Hold
150
– – ﹤0.01% 775
2023
Q1 		$16.4K Hold
150
– – ﹤0.01% 786
2022
Q4 		$17.1K Sell
150
-150
-50% -$12.5K ﹤0.01% 764
2022
Q3 		$19K Hold
300
– – ﹤0.01% 713
2022
Q2 		$24K Hold
300
– – ﹤0.01% 685
2022
Q1 		$32K Hold
300
– – ﹤0.01% 670
2021
Q4 		$32K Hold
300
– – ﹤0.01% 703
2021
Q3 		$33K Buy
300
+200
+200% +$20.8K ﹤0.01% 664
2021
Q2 		$9K Hold
100
– – ﹤0.01% 875
2021
Q1 		$9K Sell
100
-1
-1% -$84 ﹤0.01% 827
2020
Q4 		$7K Buy
101
+1
+1% +$74 ﹤0.01% 842
2020
Q3 		$8K Hold
100
– – ﹤0.01% 790
2020
Q2 		$6K Hold
100
– – ﹤0.01% 812
2020
Q1 		$3K Hold
100
– – ﹤0.01% 906
2019
Q4 		$4K Buy
+100
New +$3.07K ﹤0.01% 956

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

North Star Investment Management's HZNP Position: Q4 2023 in Review

North Star Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 150 shares — an estimated $17.4K sold.

North Star Investment Management first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $33K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • North Star Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • North Star Investment Management sold 150 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $17.4K.
  • North Star Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
  • North Star Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $33K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on North Star Investment Management's 13F filing for Q4 2023, filed 10 Jan 2024.